Amit Kumar Mandal

Mesonephric Like Adenocarcinoma (MLA) is a rare aggressive carcinoma recognised in the 2020 WHO classification, with fewer than 200 cases reported worldwide. It shows KRAS mutations in 70-81% of cases, a strong association with endometriosi…